PARTNER PROGRAM — EARN UP TO 35% RECOMMENDING WHAT YOU ALREADY USE
Triple-Receptor Agonist
Partners earn up to 35% recommending compounds like this. Partner Program
For research use only. Not for human consumption. Sold exclusively for in-vitro laboratory research.
A next-generation metabolic compound targeting GIP, GLP-1, and glucagon receptors to regulate metabolism. It maximizes fat burning and appetite suppression.
Massive weight loss, obesity management, and breaking fat-loss plateaus.
Titrated starting at 1-2mg injected subcutaneously once a week.
Get restock alerts, new compounds, and subscriber-only offers — straight to your inbox.
For research use only. Unsubscribe any time.